Bausch + Lomb Corporation (BLCO)
NYSE: BLCO
· Real-Time Price · USD
15.00
0.41 (2.81%)
At close: Sep 05, 2025, 3:59 PM
15.00
0.00%
After-hours: Sep 05, 2025, 06:13 PM EDT
Bausch + Lomb Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|
| Branded and Other Generic Products Revenue | 58M | 54M | 69M | 70M | 76M | 66M | 180M | 72M |
| Branded and Other Generic Products Revenue Growth | +7.41% | -21.74% | -1.43% | -7.89% | +15.15% | -63.33% | +150.00% | n/a |
| Device Products Revenue | 472M | 448M | 476M | 455M | 445M | 424M | 1.24B | 411M |
| Device Products Revenue Growth | +5.36% | -5.88% | +4.62% | +2.25% | +4.95% | -65.78% | +201.46% | n/a |
| Other Revenues Revenue | 6M | 4M | 5M | 4M | 3M | 5M | 12M | 3M |
| Other Revenues Revenue Growth | +50.00% | -20.00% | +25.00% | +33.33% | -40.00% | -58.33% | +300.00% | n/a |
| Over the Counter Products Revenue | 482M | 409M | 462M | 420M | 447M | 395M | 1.2B | 408M |
| Over the Counter Products Revenue Growth | +17.85% | -11.47% | +10.00% | -6.04% | +13.16% | -67.17% | +194.85% | n/a |
| Pharmaceutical Products Revenue | 260M | 222M | 268M | 247M | 245M | 209M | 505M | 113M |
| Pharmaceutical Products Revenue Growth | +17.12% | -17.16% | +8.50% | +0.82% | +17.22% | -58.61% | +346.90% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Canada Revenue | 34M | 33M | 32M | 28M | 30M | 27M | 27M | 26M | 28M | 27M | 24M | 22M |
| Canada Revenue Growth | +3.03% | +3.12% | +14.29% | -6.67% | +11.11% | 0.00% | +3.85% | -7.14% | +3.70% | +12.50% | +9.09% | n/a |
| China Revenue | 96M | 92M | 93M | 77M | 94M | 87M | 89M | 74M | 92M | 93M | 76M | 82M |
| China Revenue Growth | +4.35% | -1.08% | +20.78% | -18.09% | +8.05% | -2.25% | +20.27% | -19.57% | -1.08% | +22.37% | -7.32% | n/a |
| France Revenue | 51M | 52M | 64M | 60M | 45M | 47M | 62M | 56M | 41M | 43M | 56M | 55M |
| France Revenue Growth | -1.92% | -18.75% | +6.67% | +33.33% | -4.26% | -24.19% | +10.71% | +36.59% | -4.65% | -23.21% | +1.82% | n/a |
| Germany Revenue | 32M | 38M | 40M | 42M | 32M | 33M | 40M | 42M | 32M | 30M | 33M | 43M |
| Germany Revenue Growth | -15.79% | -5.00% | -4.76% | +31.25% | -3.03% | -17.50% | -4.76% | +31.25% | +6.67% | -9.09% | -23.26% | n/a |
| Italy Revenue | 23M | 22M | 23M | 23M | 21M | 19M | 22M | 20M | 15M | 16M | 21M | 20M |
| Italy Revenue Growth | +4.55% | -4.35% | 0.00% | +9.52% | +10.53% | -13.64% | +10.00% | +33.33% | -6.25% | -23.81% | +5.00% | n/a |
| Japan Revenue | 50M | 45M | 43M | 42M | 48M | 45M | 46M | 48M | 49M | 46M | 47M | 50M |
| Japan Revenue Growth | +11.11% | +4.65% | +2.38% | -12.50% | +6.67% | -2.17% | -4.17% | -2.04% | +6.52% | -2.13% | -6.00% | n/a |
| Mexico Revenue | 20M | 18M | 20M | 17M | 18M | 19M | 15M | 16M | 16M | 14M | 14M | 11M |
| Mexico Revenue Growth | +11.11% | -10.00% | +17.65% | -5.56% | -5.26% | +26.67% | -6.25% | 0.00% | +14.29% | 0.00% | +27.27% | n/a |
| Other Countries Revenue | 244M | 174M | 175M | 166M | 214M | 150M | 152M | 139M | 157M | 142M | 138M | 126M |
| Other Countries Revenue Growth | +40.23% | -0.57% | +5.42% | -22.43% | +42.67% | -1.32% | +9.35% | -11.46% | +10.56% | +2.90% | +9.52% | n/a |
| Poland Revenue | 15M | 17M | 18M | 15M | 14M | 11M | 14M | 12M | 11M | 10M | 12M | 11M |
| Poland Revenue Growth | -11.76% | -5.56% | +20.00% | +7.14% | +27.27% | -21.43% | +16.67% | +9.09% | +10.00% | -16.67% | +9.09% | n/a |
| Spain Revenue | 26M | 20M | 25M | 21M | 23M | 18M | 24M | 20M | 21M | 15M | 22M | 19M |
| Spain Revenue Growth | +30.00% | -20.00% | +19.05% | -8.70% | +27.78% | -25.00% | +20.00% | -4.76% | +40.00% | -31.82% | +15.79% | n/a |
| United States And Puerto Rico Revenue | 657M | 609M | 610M | 537M | 593M | 471M | 466M | 404M | 454M | 425M | 430M | 386M |
| United States And Puerto Rico Revenue Growth | +7.88% | -0.16% | +13.59% | -9.44% | +25.90% | +1.07% | +15.35% | -11.01% | +6.82% | -1.16% | +11.40% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 579M | 563M | 532M | 511M | 535M | 504M | 483M | 418M | 417M | 418M | 386M | 381M | 368M | 343M | 365M | 348M | 358M | 318M | 331M | 312M | 305M | 305M |
| Selling, General, and Administrative Revenue Growth | +2.84% | +5.83% | +4.11% | -4.49% | +6.15% | +4.35% | +15.55% | +0.24% | -0.24% | +8.29% | +1.31% | +3.53% | +7.29% | -6.03% | +4.89% | -2.79% | +12.58% | -3.93% | +6.09% | +2.30% | 0.00% | n/a |
| Research and Development Revenue | 96M | 86M | 93M | 84M | 84M | 82M | 80M | 82M | 85M | 77M | 78M | 77M | 75M | 77M | 70M | 63M | 71M | 67M | 66M | 61M | 63M | 63M |
| Research and Development Revenue Growth | +11.63% | -7.53% | +10.71% | 0.00% | +2.44% | +2.50% | -2.44% | -3.53% | +10.39% | -1.28% | +1.30% | +2.67% | -2.60% | +10.00% | +11.11% | -11.27% | +5.97% | +1.52% | +8.20% | -3.17% | 0.00% | n/a |